{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T07:45:40Z","timestamp":1767858340928,"version":"3.49.0"},"reference-count":27,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,2]]},"DOI":"10.3892\/or.2012.2178","type":"journal-article","created":{"date-parts":[[2012,12,10]],"date-time":"2012-12-10T11:33:18Z","timestamp":1355139198000},"page":"413-418","source":"Crossref","is-referenced-by-count":10,"title":["Increased expression of placental growth factor in high-grade endometrial carcinoma"],"prefix":"10.3892","volume":"29","author":[{"given":"LIEVE","family":"COENEGRACHTS","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"STEFANIE","family":"SCHRAUWEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RITA","family":"VAN BREE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"EVELYN","family":"DESPIERRE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"CATHERINE","family":"LUYTEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"BART","family":"JONCKX","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JEAN MARIE","family":"STASSEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"IGNACE","family":"VERGOTE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FR\u00c9D\u00c9RIC","family":"AMANT","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2012,12,10]]},"reference":[{"key":"key20180107214337_b1-or-29-02-0413","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"key20180107214337_b2-or-29-02-0413","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ygyno.2011.09.036","article-title":"The dualistic model of endometrial cancer: the challenge of classifying grade 3 endometrioid carcinoma","volume":"127","author":"Zannoni","year":"2012","journal-title":"Gynecol Oncol"},{"key":"key20180107214337_b3-or-29-02-0413","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0140-6736(05)67063-8","article-title":"Endometrial cancer","volume":"366","author":"Amant","year":"2005","journal-title":"Lancet"},{"key":"key20180107214337_b4-or-29-02-0413","doi-asserted-by":"crossref","first-page":"7487","DOI":"10.1158\/1078-0432.CCR-07-1017","article-title":"Clinical and biological significance of vascular endothelial growth factor in endometrial cancer","volume":"13","author":"Kamat","year":"2007","journal-title":"Clin Cancer Res"},{"key":"key20180107214337_b5-or-29-02-0413","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1525-1438.2005.00132.x","article-title":"Angiogenesis in gynecological oncology-mechanism of tumor progression and therapeutic targets","volume":"15","author":"Rasila","year":"2005","journal-title":"Int J Gynecol Cancer"},{"key":"key20180107214337_b6-or-29-02-0413","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0959-8049(99)00201-4","article-title":"Vascular endothelial growth factor and platelet-derived endothelial cell growth factor expression are implicated in the angiogenesis of endometrial cancer","volume":"36","author":"Seki","year":"2000","journal-title":"Eur J Cancer"},{"key":"key20180107214337_b7-or-29-02-0413","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1158\/0008-5472.CAN-05-1163","article-title":"Vascular proliferation is important for clinical progress of endometrial cancer","volume":"66","author":"Stefansson","year":"2006","journal-title":"Cancer Res"},{"key":"key20180107214337_b8-or-29-02-0413","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJMra0706596","article-title":"Tumor angiogenesis","volume":"358","author":"Kerbel","year":"2008","journal-title":"N Engl J Med"},{"key":"key20180107214337_b9-or-29-02-0413","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nrc2524","article-title":"FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy?","volume":"8","author":"Fischer","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"key20180107214337_b10-or-29-02-0413","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/87904","article-title":"Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions","volume":"7","author":"Carmeliet","year":"2001","journal-title":"Nat Med"},{"key":"key20180107214337_b11-or-29-02-0413","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cell.2007.08.038","article-title":"Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels","volume":"131","author":"Fischer","year":"2007","journal-title":"Cell"},{"key":"key20180107214337_b12-or-29-02-0413","doi-asserted-by":"crossref","first-page":"6537","DOI":"10.1158\/0008-5472.CAN-09-4092","article-title":"Anti-placental growth factor reduces bone metastasis by blocking tumor cell engraftment and osteoclast differentiation","volume":"70","author":"Coenegrachts","year":"2010","journal-title":"Cancer Res"},{"key":"key20180107214337_b13-or-29-02-0413","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.cell.2010.02.039","article-title":"Further pharmacological and genetic evidence for the efficacy of PlGF inhibition in cancer and eye disease","volume":"141","author":"Van de Veire","year":"2010","journal-title":"Cell"},{"key":"key20180107214337_b14-or-29-02-0413","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10549-012-1957-0","article-title":"Prognostic impact of placenta growth factor and vascular endothelial growth factor A in patients with breast cancer","volume":"133","author":"Maae","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"key20180107214337_b15-or-29-02-0413","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1016\/j.ejca.2005.07.022","article-title":"Placenta growth factor is over-expressed and has prognostic value in human breast cancer","volume":"41","author":"Parr","year":"2005","journal-title":"Eur J Cancer"},{"key":"key20180107214337_b16-or-29-02-0413","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/gut.2004.050831","article-title":"Placenta growth factor expression is correlated with survival of patients with colorectal cancer","volume":"54","author":"Wei","year":"2005","journal-title":"Gut"},{"key":"key20180107214337_b17-or-29-02-0413","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/path.1060","article-title":"Angiogenic co-operation of VEGF and stromal cell TP in endometrial carcinomas","volume":"196","author":"Sivridis","year":"2002","journal-title":"J Pathol"},{"key":"key20180107214337_b18-or-29-02-0413","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ijgo.2009.02.012","article-title":"Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium","volume":"105","author":"Pecorelli","year":"2009","journal-title":"Int J Gynaecol Obstet"},{"key":"key20180107214337_b19-or-29-02-0413","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/nm731","article-title":"Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1","volume":"8","author":"Luttun","year":"2002","journal-title":"Nat Med"},{"key":"key20180107214337_b20-or-29-02-0413","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.cyto.2010.12.007","article-title":"Serum VEGF levels and tissue activation of VEGFR2\/KDR receptors in patients with breast and gynecologic cancer","volume":"53","author":"Koukourakis","year":"2011","journal-title":"Cytokine"},{"key":"key20180107214337_b21-or-29-02-0413","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/MPA.0b013e318164548a","article-title":"Serum vascular endothelial growth factor\/soluble vascular endothelial growth factor receptor 1 ratio is an independent prognostic marker in pancreatic cancer","volume":"37","author":"Chang","year":"2008","journal-title":"Pancreas"},{"key":"key20180107214337_b22-or-29-02-0413","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.athoracsur.2009.04.038","article-title":"Placenta growth factor expression has prognostic value in malignant pleural mesothelioma","volume":"88","author":"Pompeo","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"key20180107214337_b23-or-29-02-0413","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1007\/DCR.0b013e3181afbdaf","article-title":"Preoperative serum placenta growth factor level is a prognostic biomarker in colorectal cancer","volume":"52","author":"Wei","year":"2009","journal-title":"Dis Colon Rectum"},{"key":"key20180107214337_b24-or-29-02-0413","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/1477-7819-3-68","article-title":"Expression of placenta growth factor (PlGF) in non-small cell lung cancer (NSCLC) and the clinical and prognostic significance","volume":"3","author":"Zhang","year":"2005","journal-title":"World J Surg Oncol"},{"key":"key20180107214337_b25-or-29-02-0413","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.canlet.2004.05.020","article-title":"The significance of placenta growth factor in angiogenesis and clinical outcome of human gastric cancer","volume":"213","author":"Chen","year":"2004","journal-title":"Cancer Lett"},{"key":"key20180107214337_b26-or-29-02-0413","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ygyno.2011.07.030","article-title":"Should grade 3 endometrioid endometrial carcinoma be considered a type 2 cancer-A clinical and pathological evaluation","volume":"124","author":"Voss","year":"2012","journal-title":"Gynecol Oncol"},{"key":"key20180107214337_b27-or-29-02-0413","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.clinthera.2011.08.007","article-title":"Monoclonal antibody TB-403: a first-in-human, Phase I, double-blind, dose escalation study directed against placental growth factor in healthy male subjects","volume":"33","author":"Martinsson-Niskanen","year":"2011","journal-title":"Clin Ther"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2012.2178\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T21:43:49Z","timestamp":1515361429000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2012.2178"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12,10]]},"references-count":27,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,12,10]]},"published-print":{"date-parts":[[2013,2]]}},"alternative-id":["10.3892\/or.2012.2178"],"URL":"https:\/\/doi.org\/10.3892\/or.2012.2178","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,10]]}}}